NCT03941873 2024-10-26A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction CancerBeiGenePhase 1/2 Completed111 enrolled 22 charts